Company / EPS (Diluted)
Axogen, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.51
FY2025
5-year range
-$0.74 / -$0.51
FY2021-FY2025
Trend
+26.1%
vs FY2024
Sector context
#108 of 159
Health Care
What the data says
At $-0.51, Axogen, Inc.'s eps (diluted) ranks #108 of 159 in the Health Care sector. EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $-0.51.
Based on SEC 10-K filings.
-0.51 in FY2025.
Improved from $-0.65 to $-0.51 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#108 of 159 in Health CareTop 68% of 159This company -$0.51 Sector average $1.67
▼
-130.6% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 26.1% year-over-year.
- Ranks #108 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2019.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- Negative profit margin: -5.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.51 | +26.1% |
| FY2024 | -$0.69 | -6.2% |
| FY2023 | -$0.65 | -8.3% |
| FY2022 | -$0.60 | +18.9% |
| FY2021 | -$0.74 | -23.3% |
| FY2020 | -$0.60 | -93.5% |
| FY2019 | -$0.31 | +34.0% |
| FY2018 | -$0.47 | +7.8% |
| FY2017 | -$0.51 | +0.0% |
| FY2016 | -$0.51 | +48.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026